Detecting common CFTR mutations by reverse dot blot hybridization method in cystic fibrosis first report from Northern Iran

Iranian Journal of Pediatrics

Volumn 21, Issue 1, 2011, Pages 51-57

  Dooki, Mohammad Reza Esmaeili ^a   Akhavan Niaki, Haleh ^a   Juibary, Ali Ghabeli ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CFTR; Children; Cystic fibrosis; DeltaF508 CFTR; Genotype; Iran

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CYSTIC FIBROSIS; DOT HYBRIDIZATION; FEMALE; GENE FREQUENCY; GENE LOCATION; GENE MUTATION; GENE PROBE; GENETIC RISK; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; IRAN; MALE; MUTATIONAL ANALYSIS; NEWBORN; SCHOOL CHILD;

EID: 79952938712     PISSN: 10184406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Rowntree RK, Harris A. The phenotype consequences of CFTR mutations. Ann Hum Genet 2003; 67(Pt 5):471-85.
2. Welsh MJ, Ramsey BW, Accurso F, Cutting G. Cystic fibrosis. In. Scriver CR, Beaudet AL, Sly WS, Valle D, (eds). The Metabolic and Molecular Basis of Inherited Diseases. 8th ed. New York: McGraw-Hill. 2001; Pp: 5121-88.
3. Farrell P. Improving the health of patients with cystic fibrosis through newborn screening. Adv Pediatr 2000; 49:79-115.
4. Dawson K, Frossard P. The geographic distribution of cystic fibrosis mutations gives clues about population origins. Eur J Pediatr 2000; 159(7):496-499.
5. Estivill X, Bancells C, Ramos C. Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium. Hum Mutat 1997; 10(2):135-54.
6. Mateu E. Can a place of origin of the main cystic fibrosis mutations be identified? Am J Hum Genet 2002; 70(1):257-64.
7. Jalalirad M, Houshmand M, Mirfakhraie R, et al. First study of CF mutations in the CFTR gene of Iranian patients: detection of DeltaF508, G542X, W1282X, A120T, R117H, and R347H mutations. J Trop Pediatr 2004; 50(6):359-361.
8. Elahi E, Khodadad A, Kupershmidt I, et al. A haplotype framework for cystic fibrosis mutations in Iran. J Mol Diagnostics 2006; 8(1): 119-27.
9. Alibakhshi R, Kianishirazi R, Cassiman JJ, et al. Analysis of the CFTR gene in Iranian cystic fibrosis patients. Identification of eight novel mutations. J Cyst Fibros 2008; 7(2):102-9.
10. Eshaque B, Dixon B. Technology platforms for molecular diagnosis of cystic fibrosis. Biotechnol Adv 2006; 24(1):86-93.
11. Picci L, Cameran M, Marangon O, et al. A 10-year large-scale cystic fibrosis carrier screening in the Italian population. J Cyst Fibros 2010; 9(1):29-35.
12. Huber K, Mirkovic B, Nersesian R, et al. Survey of CF mutations in the clinical laboratory. BMC Clin Pathol 2002; 2(1):4-11.
13. Dequeker E, Stuhrmann M, Morris MA, et al. Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders - updated European recommendations. Eur J Hum Genet 2009; 17(1):51-65.
14. Stuppia L, Antonucci I, Binni F, et al. Screening of mutations in the CFTR gene in 1195 couples entering assisted reproduction technique programs. Eur J Hum Genet 2005; 13(8):959-64.
15. Tomaiuolo R, Spina M, Castaldo G. Molecular Diagnosis of Cystic Fibrosis. Comparison of four analytical procedures. Clin Chem Lab Med 2003; 41(1):26-32.
16. Lappin S, Cahlik J, Gold B. Robot printing of reverse dot blot arrays for human mutation detection. J Mol.Diagn 2001; 3(4):178-88.
17. Bonyadi M, Omrani O, Moghanjoghi SM, et al. Mutations of the phenylalanine hydroxylase gene in Iranian Azeri Turkish patients with phenylketonuria. Genet Test Mol Biomarkers 2010; 14(2):233-5.
18. Abolghasemi H, Amid A, Zeinali S, et al. Thalassemia in Iran. Epidemiology, prevention, and management. J Pediatr Hematol Oncol 2007; 29(4):233-8.
19. Derakhshandeh-Peykar P, Akhavan-Niaki H, Tamaddoni A, et al. Distribution of betathalassemia mutations in the northern provinces of Iran. Hemoglobin 2007; 31(3):351-6.
20. Loumi O, Ferec C, Mercier B, et al. CFTR mutations in the Algerian population. J Cyst Fibros 2008; 7(1):54-9.
21. Bobadilla JL, Macek M Jr, Fine JP, Farrel PM. Cystic fibrosis, a worldwide analysis of CFTR mutations - correlation with incidence data and application to screening. Hum Mutat 2002; 19(6):575-606.
22. Lao O, Andrés AM, Mateu E, et al. Spatial patterns of cystic fibrosis mutation spectra in European populations. Eur J Hum Genet 2003; 11(5):385-94.
23. Yilmaz E, Erdem H, Ozgüç M, et al. Study of 12 mutations in Turkish cystic fibrosis patients. Hum Hered 1995; 45(3):175-7.
24. Sharma N, Singh M, Kaur G, et al. Identification and characterization of CFTR gene mutations in Indian CF patients. Ann Hum Genet 2009; 73(1): 26-33.
25. Hundrieser J, Bremer S, Peinemann F, et al. Frequency of the F508 deletion in the CFTR gene in Turkish cystic fibrosis patients. Hum Genet 1990; 85(4):409-10.
26. Kabra SK, Kabra M, Lodha R, et al. Clinical profile and frequency of delta f508 mutation in Indian children with cystic fibrosis. Indian Pediatr 2003; 40(7):612-9.
27. Banjar H, Kambouris M, Meyer BF, et al. Geographic distribution of cystic fibrosis transmembrane regulator gene mutations in Saudi Arabia. Ann Trop Paediatr 1999; 19(1):69-73.
28. Banjar H. Geographic distribution of cystic fibrosis transmembrane regulator gene mutations in Saudi Arabia. East Mediter Health J 1999; 5(6):1230-5.
29. Kilinç M, Ninis V, Dagli E, et al. Highest heterogeneity for cystic fibrosis. 36 mutations account for 75% of all CF chromosomes in Turkish patients. Am J Hum Genet 2002; 113(3): 250-7.
30. Shah U, Frossard P, Moatter T. Cystic fibrosis. defining a disease under-diagnosed in Pakistan. Trop Med Int Health 2009; 14(5):542-5.
31. Loirat F, Hazout S, Lucotte G. G542X as a probable Phoenician cystic fibrosis mutation. Hum Biol 1997; 69(3):419-25.
32. Navarro H, Kolbach M, Repetto G, et al. Correlation between phenotype and genotype in a group of patients with cystic fibrosis. Rev Med Chil 2002; 130(5):475-81.
33. Feingold J, Guilloud-Bataille M. Genetic comparisons of patients with cystic fibrosis with or without meconium ileus. Clinical Centers of the French CF Registry. Ann Genet 1999; 42(3): 147-50.
34. Akata D, Akhan O. Liver manifestations of cystic fibrosis. Eur J Radiol 2007; 61(1):11-7.
35. Penmatsa H, Frederick CA, Nekkalapu S, et al. Clinical and molecular characterization of S1118F-CFTR. Pediatr Pulmonol 2009; 44(10): 1003-9.
36. Chiba-Falek O, Nissim-Rafinia M, Argaman Z, et al. Screening of CFTR mutations in an isolated population. Identification of carriers and patients. Eur J Hum Genet 1998; 6(2):181-4.